Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €1.80 EUR
Change Today -0.015 / -0.83%
Volume 0.0
3A0 On Other Exchanges
Symbol
Exchange
Frankfurt
As of 1:54 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

amyris inc (3A0) Snapshot

Open
€1.80
Previous Close
€1.81
Day High
€1.82
Day Low
€1.79
52 Week High
08/27/14 - €3.35
52 Week Low
01/21/15 - €1.39
Market Cap
143.8M
Average Volume 10 Days
103.5
EPS TTM
--
Shares Outstanding
79.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMYRIS INC (3A0)

amyris inc (3A0) Related Businessweek News

No Related Businessweek News Found

amyris inc (3A0) Details

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products for the consumer care, specialty chemical, and transportation fuel markets worldwide. The company applies its industrial synthetic biology platform to design microbes and primarily yeast, as well as to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and various materials for performance materials market; renewable fuels for transportation fuels market; and base oils for lubricants market. It has a collaboration partnership with Total to commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

416 Employees
Last Reported Date: 05/7/15
Founded in 2003

amyris inc (3A0) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $550.0K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $300.0K
President of Research and Development
Total Annual Compensation: $358.8K
Compensation as of Fiscal Year 2014.

amyris inc (3A0) Key Developments

Amyris, Inc. Presents at Cowen and Company 43rd Annual Technology, Media & Telecom Conference 2015, May-28-2015 02:45 PM

Amyris, Inc. Presents at Cowen and Company 43rd Annual Technology, Media & Telecom Conference 2015, May-28-2015 02:45 PM. Venue: The New York Palace Hotel, 455 Madison Avenue, New York, NY 10022, United States. Speakers: John G. Melo, Chief Executive Officer, President and Director.

Amyris, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Revenue Guidance for the Full Year of 2015

Amyris, Inc. total revenues were $7,872,000 against $6,041,000 a year ago. Loss from operations was $25,162,000 against $26,687,000 a year ago. Loss before income taxes and loss from investments in affiliates was $51,339,000 against income before income taxes and loss from investments in affiliates of $16,467,000 a year ago. Net loss before loss from investments in affiliates was $51,454,000 against net income before loss from investments in affiliates of $16,356,000 a year ago. Net loss attributable to the company common stockholders was $52,240,000 against net income attributable to the company common stockholders of $16,385,000 a year ago. Diluted net loss per share attributable to common stockholders was $0.66 against $0.34 a year ago. Net loss attributable to the company common stockholders (Non-GAAP) was $32,176,000 against $28,071,000 a year ago. Net loss per share attributable to the common stockholders, (Non-GAAP) was $0.41 against $0.37 a year ago. Net cash flow was $1.7 million. The company expects a strong second half in product revenue and collaboration inflows with strong support for delivering on its 2015 cash revenue inflows target of between $100 million to $110 million.

Amyris, Inc. to Report Q1, 2015 Results on May 05, 2015

Amyris, Inc. announced that they will report Q1, 2015 results at 4:30 PM, US Eastern Standard Time on May 05, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3A0:GR €1.80 EUR -0.015

3A0 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AJ Greentech Holdings Ltd $0.0055 USD 0.00
American Power Group Corp $0.18 USD 0.00
China Clean Energy Inc $0.07 USD 0.00
Gevo Inc $3.07 USD -0.53
Solazyme Inc $3.15 USD -0.09
View Industry Companies
 

Industry Analysis

3A0

Industry Average

Valuation 3A0 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.5x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMYRIS INC, please visit www.amyris.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.